Abridge vs Immunai

Abridge vs Immunai, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Abridge is on 68/100 and Immunai on 69/100.

Abridge logo
AbridgeAbridge provides enterprise-grade generative AI for clinical conversations, transforming patient-clinician interactions into contextually aware, clinically useful, and billable AI-generated notes for healthcare systems.
Try Abridge
Immunai logo
ImmunaiMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
Try Immunai

Where each one leads

Abridge

  • agent readiness: 50/100 against 32/100
  • domain rating: 70/100 against 46/100
  • headcount: 623 against 179
  • LinkedIn following: 76,595 against 26,832

Immunai

Leads on none of the measures we hold for both companies.

At a glance

MeasureAbridgeImmunai
What it isAbridge provides enterprise-grade generative AI for clinical conversations, transforming patient-clinician interactions into contextually aware, clinically useful, and billable AI-generated notes for healthcare systems.Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
CategoryHealthcareHealthcare, Immunology, Data, Analytics
Sells toBusiness modelB2BB2B
OfferingNot publishedSoftware
Founded20182019
HeadquartersPittsburgh, United StatesNew York, United States
StatusActiveActive

Size, funding and growth

MeasureAbridgeImmunai
Employees623179
Headcount growthLast 12 monthsNot published+13.0%
Open roles47Not published
Total funding$300M$295M
Latest roundNot publishedSeries B
ValuationNot published$1.0B
LinkedIn followers76,59526,832

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAbridgeImmunai
StartupHub scoreOur 0-100 rating68/10069/100
Traction60/10060/100
Team50/10070/100
Search visibility56/10039/100
Quality78/10078/100
Agent readinessHow well an AI agent can read and act on the siteD (50/100)F (32/100)
Domain ratingLink authority, 0-10070/10046/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAbridgeImmunai
CDNCloudflareNot detected
CMSWebflowWordPress
FrameworksTailwind CSSJquery, Bootstrap
PaymentsStripeNot detected
AnalyticsGoogle Tag Manager, HotjarGoogle Tag Manager
Support stackZendeskNot detected

Product and pricing

MeasureAbridgeImmunai
Key featuresAI-Generated Clinical Notes, Contextual Reasoning Engine, EMR Integration, Revenue Cycle Optimization, Nursing Documentation, Scalability & VersatilityNot published

What users say

MeasureAbridgeImmunai
Reddit sentimentThreads we track1 positive, 1 negative across 6 threadsNot published
Abridge
So when I say I'm impressed after the first week, I mean it. Abridge has taken very complex patient visits (of the social nightmare variety, you know the kind) and turned it into a concise
r/FamilyMedicine

Abridge vs Immunai: common questions

Which is better, Abridge or Immunai?

On our 0-100 score Immunai rates higher (69/100 against 68/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.

How do Abridge and Immunai compare on the numbers?

Abridge leads on agent readiness (50/100 against 32/100), domain rating (70/100 against 46/100), headcount (623 against 179), LinkedIn following (76,595 against 26,832).

What do real users say about Abridge and Immunai?

Abridge: 1 positive and 1 negative mentions across 6 Reddit threads we track, mostly in r/FamilyMedicine.

Read the full Abridge review and pricing or the Immunai review and pricing. You can also browse other Abridge alternatives we track.